Skip to main content
Rheumatology and Therapy logoLink to Rheumatology and Therapy
. 2021 Oct 29;8(4):1921–1922. doi: 10.1007/s40744-021-00389-7

Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

Markus Rehberg 1, Clemens Giegerich 1, Amy Praestgaard 2, Hubert van Hoogstraten 2, Melitza Iglesias-Rodriguez 2, Jeffrey R Curtis 3, Jacques-Eric Gottenberg 4, Andreas Schwarting 5,6, Santos Castañeda 7, Andrea Rubbert-Roth 8, Ernest H S Choy 9,; the MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators
PMCID: PMC8572238  PMID: 34714512

Correction to: Rheumatol Ther 10.1007/s40744-021-00361-5

In the original article published, there is an error in the video of the supplementary material. The correct supplementary material has been updated.

The original article has been corrected.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Contributor Information

Markus Rehberg, Email: markus.rehberg@sanofi.com.

Clemens Giegerich, Email: clemens.giegerich@sanofi.com.

Amy Praestgaard, Email: amy.praestgaard@sanofi.com.

Hubert van Hoogstraten, Email: hubert.vanhoogstraten@sanofi.com.

Melitza Iglesias-Rodriguez, Email: melitza.iglesias-rodriguez@sanofi.com.

Jeffrey R. Curtis, Email: jrcurtis@uabmc.edu

Jacques-Eric Gottenberg, Email: jegotten@gmail.com.

Andreas Schwarting, Email: schwarting@uni-mainz.de.

Santos Castañeda, Email: scastas@gmail.com.

Andrea Rubbert-Roth, Email: andrea.rubbert-roth@kssg.ch.

Ernest H. S. Choy, Email: choyeh@cardiff.ac.uk

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Rheumatology and Therapy are provided here courtesy of Springer

RESOURCES